PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
08-Apr-2024 MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth MMS
08-Apr-2024 BEVESPI AEROSPHERE (GLYCOPYRRONIUM BROMIDE/FORMOTEROL FUMARATE) ACCEPTED FOR USE IN NHS SCOTLAND FOR ADULT PATIENTS WITH CHRONIC PULMONARY RESPIRATORY DISEASE (COPD) BY THE SCOTTISH MEDICINES CONSORTIUM (SMC) BEVESPI AEROSPHERE
08-Apr-2024 Royal Bournemouth Hospital UK’s first to install Canon Medical's new Aquilion ONE / INSIGHT Edition CT system Royal Bournemouth Hospital
08-Apr-2024 Nxera Pharma joins the World Orphan Drug Alliance Nxera Pharma
08-Apr-2024 Cannabis use during pregnancy linked to increased risk of ADHD, autism and intellectual disability in children European Psychiatric Association Congress
08-Apr-2024 Application submitted to include an additional terbinafine supplier Moberg Pharma AB
08-Apr-2024 First Preclinical Data on Parkinson’s Disease Program to be presented at the American Society of Gene & Cell Therapy 27th Annual Meeting 2024 Bloomsbury Genetic Therapies Limited
05-Apr-2024 FDA Accepts Supplemental Biologics License Applications for BIMZELX® (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations UCB
05-Apr-2024 MRNA CMC HARMONIZATION, MANUFACTURING & ANALYTICAL TO BE DISCUSSED BY VERNAL EXPERTS AT INDUSTRY CONFERENCES Vernal Biosciences
05-Apr-2024 Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research Biognosys
05-Apr-2024 Chiesi’s carbon minimal inhalers reach innovation milestone as phase III trials now underway Chiesi Group
05-Apr-2024 PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab PolTREG
05-Apr-2024 Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives Alterome Therapeutics, Inc.
05-Apr-2024 Ariceum Therapeutics to present new radioligand therapy data at American Association for Cancer Research (AACR) Annual Meeting 2024 Ariceum Therapeutics
05-Apr-2024 EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials EnteroBiotix
03-Apr-2024 Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC Nxera Pharma
03-Apr-2024 Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence Agilent Technologies
03-Apr-2024 Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development SimBioSys, Inc.
03-Apr-2024 EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS) EnteroBiotix Limited
03-Apr-2024 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio Genmab A/S